Hims & Hers Health (HIMS) Expands into Canada with a New Weight Loss Program
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc.
Posts Tagged ‘NYSE:HIMS’
Hims & Hers (HIMS) Jumps 14.4% W/W Ahead of Q2 Earnings
Telehealth giant Hims & Hers saw its share prices increase by 14.4 percent week-on-week, from $50.38 to $57.65 on Friday, as investors began repositioning portfolios ahead of ...
10 Stocks With Huge Catalysts on the Horizon
The August 1 tariff deal is approaching; however, the market seems to have gotten used to the tariff headlines.
Hims & Hers (HIMS) Soars 16% on Bullish Analyst Outlook
Hims & Hers rallied for a second day on Wednesday, adding 16.02 percent to close at $58.02 apiece as investors took path from an investment firm’s bullish outlook and rating...
Hims & Hers Health, Inc. (HIMS) Announces Expansion To Canada
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now.
Hims (HIMS) Jumps 8.6% as Firm Still Open to Work With Novo
Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite the termination...
Hims & Hers (HIMS): A Bear Case Theory
We came across a bearish thesis on Hims & Hers on FJ Research's Substack. As of 3ʳᵈ July, Hims & Hers's share was trading at $47.98.
13 Best Booming Stocks to Buy Now
A day after posting a new record high, the S&P 500 closed 0.33% lower on Friday due to an escalation in the trade war, with President Trump announcing a 35% tariff on Canada and...
Hims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Hims & Hers Health, Inc.
14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the recent Bitcoin price jumps.
Hims & Hers Expands into Europe with ZAVA Acquisition
Hims & Hers Health Inc. (NYSE:HIMS) is one of the best NYSE stocks to buy for long term investment.
10 Best NYSE Stocks to Buy for Long Term Investment
On June 16, Stephanie Link, Hightower Advisors' chief investment strategist and portfolio manager, joined CNBC's ‘Squawk Box’ to discuss the latest market trends.
Hims & Hers (HIMS) Jumps 6.76% Anew as Investors Cheer Weight Loss Drug Fight
Hims & Hers extended its rally for the second day on Friday, adding 6.76 percent to close at $49.41 apiece after its chief executive’s reaffirmation that the company will continue...
Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat
Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper compounded versions of GLP-1 weight-loss drugs, despite...
14 Stocks Jim Cramer Recently Shared Insights On
On Tuesday’s episode of Mad Money, host Jim Cramer delivered a clear message to investors chasing speculative stocks: stay disciplined, even when your convictions feel strong...
Hims & Hers (HIMS) Slashes 34.6% as Novo Nordisk Terminates Partnership
In a statement, Novo Nordisk said it ended its collaboration with Hims & Hers Health, Inc.
Hims & Hers Health (HIMS) Surged on Weight Loss Offering Advertisement Campaign
Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2025 investor letter.
Here’s Why Hims & Hers Health (HIMS) Soared in Q1
Renaissance Investment Management, an investment management company, released its Q1 2025 “Small Cap Growth Strategy” investor letter.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on M. V. Cunha’s Substack. In this article, we will summarize the bulls’ thesis on HIMS.
Needham Lifts PT on Hims & Hers Health (HIMS) Stock, Maintains Buy Rating
On June 4, Needham upped the price objective on Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS) to Buy European Telehealth Firm as Part of Global Growth Strategy
The company stated that the deal is expected to be finalized by mid-year.
Why Hims & Hers Health, Inc. (HIMS) Surged On Friday
We recently published a list of Investors Rushed Into These 10 Stocks Today.
Why Hims & Hers Health Inc. (HIMS) Went Down On Tuesday
We recently published a list of 10 Stocks Got Wiped Out. Are You Holding Any? In this article, we are going to take a look at where Hims & Hers Health Inc.
Why Hims & Hers Health, Inc. (HIMS) Skyrocketed on Friday
We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at where Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript May 5, 2025Hims & Hers Health, Inc. beats earnings expectations.
10 Best Telehealth Stocks to Buy Now
According to Grand View Research, the telehealth market size in the US was valued at $42.54 billion in 2024.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741.
Here’s Cedar Grove Capital Management’s Takeaway from Its Short Position Hims and Hers Health (HIMS)
Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Hims & Hers Health (HIMS) is Growing Revenue And Profitability
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2025 investor letter.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS.
Why These 15 Defensive Stocks Are Surging In 2025
Defensive stocks are surging as investors have been shifting their focus. Growth stocks dominated the past two years.
12 Most Shorted Stocks in 2025
Reuters reported that President Trump’s tariffs have impacted the broader stock markets, weighing on investors’ sentiments, as worries related to the economic slowdown drove...
15 Stocks That Outperform the S&P 500 Every Year For the Last 3 Years
Imagine choosing a group of stocks that not only weathered the market’s storm but also outpaced its peers. Clearly, a win.
10 Best Skincare Stocks to Buy According to Hedge Funds
According to NielsenIQ, the global beauty market is expected to increase by 7.3% annually to reach $1 trillion in 2025, with Latin America by 19.1% and Africa-Middle East by 27...
Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on a late-hours market selloff. Cramer shared that he was "tired of it [the selloff].
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS.
Jim Cramer on 10 Stocks With The Biggest Declines Last Week
On Monday, Jim Cramer, the host of Mad Money, analyzed the 10 largest stocks that suffered the most significant declines the previous week.
Why Hims & Hers (HIMS) Stock Is Tumbling
Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today.
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2024 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2024 Earnings Call Transcript February 24, 2025Hims & Hers Health, Inc. beats earnings expectations.
Jim Cramer Discusses These 12 Stocks & Trump DOJ’s Action Against Health Insurance Companies
In his recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on a report in the Wall Street Journal suggesting that the Trump administration's Department of Justice...
Jim Cramer’s Game Plan: 17 Stocks in Focus
On Friday, Jim Cramer, the host of Mad Money, took time to guide investors through this week’s events on Wall Street, drawing attention to earnings reports from various companies...
Why Hims & Hers Health (HIMS) Is Rallying Today
By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more comprehensive whole body testing," HIMS reported.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Lorenzo’s 2 cents. In this article, we will summarize the bulls’ thesis on HIMS.
Jim Cramer Shed Light on These 8 Stocks Recently
Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald Trump’s recent actions and his effect on the stock market, urging investors to pay closer...
12 Best Beauty Stocks to Buy According to Hedge Funds
According to a report by McKinsey, in 2023, the global beauty market expanded by 10%, reaching $446 billion in retail sales, mostly due to price hikes rather than volume advances...
5 Stocks That Started The Year On A High
Anyone who’s looked at the market in the last couple of weeks will know that there were some events that shook investors.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS.
